Healthcare provider profile · identity verified

Michael J. Hemsworth, MD

Family Practice · COLORADO SPRINGS, CO · NPI 1124095641

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	568	153
Levothyroxine Sodium	Levothyroxine Sodium	414	104
Losartan Potassium	Losartan Potassium	358	99
Lisinopril	Lisinopril	313	86
Amlodipine Besylate	Amlodipine Besylate	303	80
Omeprazole	Omeprazole	257	80
Metformin Hcl	Metformin Hcl	206	59
Gabapentin	Gabapentin	203	51
Trazodone Hcl	Trazodone Hcl	163	48
Tamsulosin Hcl	Tamsulosin Hcl	162	49
Zolpidem Tartrate	Zolpidem Tartrate	141	26
Duloxetine Hcl	Duloxetine Hcl	138	30
Alprazolam	Alprazolam	131	27
Metoprolol Succinate	Metoprolol Succinate	127	37
Hydrochlorothiazide	Hydrochlorothiazide	123	37
Alendronate Sodium	Alendronate Sodium	119	39
Meloxicam	Meloxicam	119	44
Eliquis	Apixaban	113	20
Metoprolol Tartrate	Metoprolol Tartrate	108	26
Rosuvastatin Calcium	Rosuvastatin Calcium	108	27
Pantoprazole Sodium	Pantoprazole Sodium	106	29
Allopurinol	Allopurinol	105	30
Potassium Chloride	Potassium Chloride	99	28
Simvastatin	Simvastatin	99	31
Escitalopram Oxalate	Escitalopram Oxalate	91	21
Furosemide	Furosemide	86	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	22
Bupropion Xl	Bupropion Hcl	78	24
Glipizide	Glipizide	77	21
Lorazepam	Lorazepam	74	14
Tramadol Hcl	Tramadol Hcl	74	18
Albuterol Sulfate Hfa	Albuterol Sulfate	73	29
Citalopram Hbr	Citalopram Hydrobromide	70	21
Oxycodone Hcl	Oxycodone Hcl	65	11
Clonazepam	Clonazepam	64	11
Carvedilol	Carvedilol	63	17
Sertraline Hcl	Sertraline Hcl	62	15
Finasteride	Finasteride	60	17
Lovastatin	Lovastatin	58	17
Mirtazapine	Mirtazapine	55	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	18
Fluticasone Propionate	Fluticasone Propionate	51	20
Pravastatin Sodium	Pravastatin Sodium	49	16
Pregabalin	Pregabalin	49	18
Montelukast Sodium	Montelukast Sodium	48	12
Oxybutynin Chloride Er	Oxybutynin Chloride	48	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	45	17
Solifenacin Succinate	Solifenacin Succinate	44	suppressed
Jardiance	Empagliflozin	42	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Temazepam	Temazepam	37	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	32	suppressed
Diazepam	Diazepam	32	suppressed
Estradiol	Estradiol	31	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Ozempic	Semaglutide	27	suppressed
Promethazine Hcl	Promethazine Hcl	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Topiramate	Topiramate	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Celecoxib	Celecoxib	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Prednisone	Prednisone	24	14
Famotidine	Famotidine	23	suppressed
Prolia	Denosumab	23	14
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Naproxen	Naproxen	22	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Atenolol	Atenolol	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Azithromycin	Azithromycin	17	16
Baclofen	Baclofen	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Cephalexin	Cephalexin	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Ramipril	Ramipril	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error